Mario Stylianou, Ph.D.
Affiliations: | 2000 | American University, Washington, DC, United States |
Area:
StatisticsGoogle:
"Mario Stylianou"Parents
Sign in to add mentor| Nancy Flournoy | grad student | 2000 | American University | |
| (Sequential analysis of Durham and Flournoy's biased coin design for phase I clinical trials.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pitcher A, Emberson J, Lacro RV, et al. (2015) Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration. American Heart Journal. 169: 605-12 |
| Lamas GA, Boineau R, Goertz C, et al. (2014) EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy. American Heart Journal. 168: 37-44.e5 |
| Lamas GA, Boineau R, Goertz C, et al. (2013) Oral high-dose multivitamins and minerals after myocardial infarction: a randomized trial. Annals of Internal Medicine. 159: 797-805 |
| Stylianou M, Follmann DA. (2004) The accelerated biased coin up-and-down design in phase I trials. Journal of Biopharmaceutical Statistics. 14: 249-60 |
| Stylianou M, Proschan M, Flournoy N. (2003) Estimating the probability of toxicity at the target dose following an up-and-down design. Statistics in Medicine. 22: 535-43 |
| Stylianou M, Flournoy N. (2002) Dose finding using the biased coin up-and-down design and isotonic regression. Biometrics. 58: 171-7 |